Our information show that CK18 is constantly expressed in different epithelial cancers, In particular adenocarcinomas. the two loss of CK18 expression in cancers derived from CK18 optimistic precursor cells and neo-expression in malignancies derived from CK18 beneficial precursors are generally linked to unfavorable tumor phenotype and disorder fin